MDM2 and cancer: A frequently cited literature review reporting aggregate data compiled from multiple studies suggested that pan-cancer MDM2 amplification rates may be as high as 7% [23], but the underlying studies used a varied array of methodologies and employed no standardized amplification copy number cutoffs.